Rapid and sensitive RP-LC method with amperometric detection for pharmacokinetic assessment of propafenone in human serum of healthy volunteers

[1]  W. Thormann,et al.  Validated capillary electrophoresis assay for the simultaneous enantioselective determination of propafenone and its major metabolites in biological samples , 2006, Electrophoresis.

[2]  C. Flores-Pérez,et al.  A Simple Method to Measure Plasma Levels of Propafenone with Fluorescence Detection , 2005 .

[3]  Walter A. Korfmacher,et al.  Chiral liquid chromatography-tandem mass spectrometric methods for stereoisomeric pharmaceutical determinations. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[4]  M. Rouini,et al.  A Rapid HPLC Assay for the Simultaneous Determination of Propafenone and Its Major Metabolites in Human Serum , 2004, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

[5]  J. Bojarşki.  Stereoselective chromatography of cardiovascular drugs: an update. , 2002, Journal of biochemical and biophysical methods.

[6]  U. Hofmann,et al.  Determination of propafenone and its phase I and phase II metabolites in plasma and urine by high-performance liquid chromatography-electrospray ionization mass spectrometry. , 2000, Journal of chromatography. B, Biomedical sciences and applications.

[7]  D. Zhong,et al.  Stereoselective pharmacokinetics of propafenone and its major metabolites in healthy Chinese volunteers. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[8]  C. Bertucci,et al.  Simultaneous determination of propafenone and 5-hydroxypropafenone enantiomers in plasma by chromatography on an amylose derived chiral stationary phase. , 1999, Journal of pharmaceutical and biomedical analysis.

[9]  E. Brandšteterová,et al.  Determination of propafenone and its main metabolite 5-hydroxypropafenone in human serum with direct injection into a column-switching chromatographic system. , 1999, Journal of Chromatography B: Biomedical Sciences and Applications.

[10]  D. Zhong,et al.  Enantioselective determination of propafenone and its metabolites in human plasma by liquid chromatography-mass spectrometry. , 1999, Journal of Chromatography B: Biomedical Sciences and Applications.

[11]  P. S. Bonato,et al.  Enantioselective analysis of propafenone in plasma using a polysaccharide-based chiral stationary phase under reversed-phase conditions. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[12]  G. Clarke,et al.  Investigation and optimisation of the use of organic modifiers in micellar electrokinetic chromatography , 1995 .

[13]  H. Duff,et al.  Clinical Pharmacokinetics of Propafenone , 1991, Clinical pharmacokinetics.

[14]  D. Roden,et al.  Drug therapy : propafenone , 1990 .

[15]  W. Breckwoldt,et al.  HPLC determination of 5-hydroxypropafenone in plasma with electrochemical detection. , 1988, Methods and findings in experimental and clinical pharmacology.

[16]  R. N. Brogden,et al.  Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias. , 1987, Drugs.

[17]  S. Higuchi,et al.  Determination of plasma protein binding of propafenone in rats, dogs and humans by highly sensitive gas chromatography-mass spectrometry. , 1985, Journal of chromatography.

[18]  M. Mantovani,et al.  Determination of propafenone in serum or plasma by electron-capture gas chromatography. , 1982, Journal of chromatography.

[19]  S. Harapat,et al.  High-performance liquid chromatographic analysis of propafenone in human plasma samples. , 1982, Journal of chromatography.